Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
The Journal of Obstetrics and Gynaecology Research|March 1, 2022
Hereditary gynecologic tumors and precision cancer medicineChikako Ogawa, Akira Hirasawa, Naoyuki Ida, et al.Molecular and Clinical Oncology|February 14, 2018
Prognostic nutritional index as a predictor of survival in patients with recurrent cervical cancerNaoyuki Ida, Keiichiro Nakamura, Masayuki Saijo, et al.Free Radical Research|May 15, 2015
Oxidative DNA damage induced by metabolites of chloramphenicol, an antibiotic drugShiho Ohnishi, Mariko Murata, Naoyuki Ida, et al.The Journal of Obstetrics and Gynaecology Research|March 3, 2025
Epithelioid trophoblastic tumor diagnosed during a thorough examination of recurrent implantation failure: A case reportYasuhiko Kamada, Junko Haraga, Naoyuki Ida, et al.The American Journal of Surgical Pathology|September 4, 2019
Histologic Appearance and Immunohistochemistry of DNA Mismatch Repair Protein and p53 in Endometrial Carcinosarcoma: Impact on Prognosis and Insights Into TumorigenesisMasayuki Saijo, Keiichiro Nakamura, Naoyuki Ida, et al.Pathology, Research and Practice|March 6, 2021
DNA mismatch repair deficiency and p53 abnormality are age-related events in mixed endometrial carcinoma with a clear cell componentNaoyuki Ida, Keiichiro Nakamura, Masayuki Saijo, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 27, 2016
Radical Hysterectomy Plus Concurrent Chemoradiation/Radiation Therapy Is Negatively Associated With Return to Work in Patients With Cervical CancerKeiichiro Nakamura, Hisashi Masuyama, Naoyuki Ida, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 11, 2018
The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer SurvivorsHirofumi Matsuoka, Keiichiro Nakamura, Yuko Matsubara, et al.Acta Medica Okayama|May 3, 2022
The Combination of D-dimer and Glasgow Prognostic Score Can Be Useful in Predicting VTE in Patients with Stage IIIC and IVA Ovarian CancerKotaro Kubo, Keiichiro Nakamura, Kazuhiro Okamoto, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 28, 2017
Glasgow prognostic score is a prognosis predictor for patients with endometrial cancerMasayuki Saijo, Keiichiro Nakamura, Hisashi Masuyama, et al.Pageof 3